Incretin Hormones: The role of GIP and GLP-1  

Written by Kelsey Schaffstall Young MS, RDN, LDN On May 13 2022, the Food and Drug Administration approved a new medication called Mounjaro (tirzepatide) for the treatment of Type 2 diabetes.1 Results from clinical trials have shown that it is even more effective at regulating blood glucose and promoting weight loss than existing diabetes drugs.1Continue reading “Incretin Hormones: The role of GIP and GLP-1  “


Something went wrong. Please refresh the page and/or try again.

About The Virtual Diabetes Education Program

Subscribe to the Blog

Get new content delivered directly to your inbox.

%d bloggers like this: